Target intelligence / Profile preview

Motor neuron cell (MN)

Target
MN
Molecular classification
Other
01

Overview

Motor neurons are specialized nerve cells located in the central nervous system, specifically within the spinal cord and brainstem, that are responsible for transmitting electrical impulses to muscles to initiate and control voluntary and involuntary movements (StatPearls, 2023). These cells are characterized by their long axons that extend to the periphery to form the neuromuscular junction, where they release neurotransmitters to trigger muscle contraction (NIH, 2024). The selective degeneration of motor neurons is the primary pathological feature of motor neuron diseases (MNDs), such as Amyotrophic Lateral Sclerosis (ALS) and Spinal Muscular Atrophy (SMA) (PubMed, 2022). While 'Motor neuron cells' represent a complex biological system rather than a single molecular target, they are the focus of intensive therapeutic development aimed at neuroprotection and genetic restoration. Current pharmacological interventions involve modulating excitatory neurotransmission, reducing oxidative stress, or utilizing advanced genetic therapies to address underlying molecular defects within these cells (Nature Reviews Neurology, 2021).

Other names
MotoneuronMotor neuronEfferent neuronLower motor neuronUpper motor neuron
02

Mechanism of action

Drugs associated with motor neuron diseases function through diverse mechanisms: Riluzole inhibits glutamate release and inactivates voltage-dependent sodium channels; Edaravone acts as a free radical scavenger to reduce oxidative stress; Nusinersen and Risdiplam modulate SMN2 gene splicing to increase functional SMN protein; Onasemnogene abeparvovec provides a functional copy of the SMN1 gene via viral vector; and Tofersen is an antisense oligonucleotide that mediates the degradation of SOD1 mRNA.

03

Biological functions

Motor controlNeuromuscular transmissionSignal transductionSynaptic transmission
04

Disease associations

Amyotrophic lateral sclerosisSpinal muscular atrophyPrimary lateral sclerosisProgressive muscular atrophyBulbar palsy
05

Safety considerations

HepatotoxicityThrombocytopeniaCoagulation abnormalitiesImmunogenicity of viral vectorsBlood-brain barrier delivery challengesInjection site reactions
06

Interacting drugs

Riluzole

5 more in the full profile.

07

Biomarkers

Neurofilament light chain (NfL)Phosphorylated neurofilament heavy chain (pNFH)Urinary p75 neurotrophin receptor extracellular domain (p75ECD)

Beyond the preview

Go deeper on Motor neuron cell (MN).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Motor neuron cell (MN).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call